These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18460733)

  • 1. [The association of complement with common connective tissue diseases - a review].
    Arason GJ
    Laeknabladid; 2008 May; 94(5):371-4. PubMed ID: 18460733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.
    Arason GJ; Kolka R; Hreidarsson AB; Gudjonsson H; Schneider PM; Fry L; Arnason A
    Clin Exp Immunol; 2005 Jun; 140(3):572-9. PubMed ID: 15932521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
    Arason GJ; Steinsson K; Kolka R; Víkingsdóttir T; D'Ambrogio MS; Valdimarsson H
    Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E; Kralikova P
    Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of anti-C1q autoantibodies to lupus nephritis.
    Tsirogianni A; Pipi E; Soufleros K
    Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement deficiencies and systemic lupus erythematosus.
    Truedsson L; Bengtsson AA; Sturfelt G
    Autoimmunity; 2007 Dec; 40(8):560-6. PubMed ID: 18075790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation in patients with primary antiphospholipid syndrome.
    Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
    Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complement system in systemic autoimmune disease.
    Chen M; Daha MR; Kallenberg CG
    J Autoimmun; 2010 May; 34(3):J276-86. PubMed ID: 20005073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-C1q autoantibodies in lupus nephritis.
    Sinico RA; Rimoldi L; Radice A; Bianchi L; Gallelli B; Moroni G
    Ann N Y Acad Sci; 2009 Sep; 1173():47-51. PubMed ID: 19758131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-C1q autoantibodies.
    Kallenberg CG
    Autoimmun Rev; 2008 Sep; 7(8):612-5. PubMed ID: 18606253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunologic anomalies in inflammatory diseases of connective tissue in children].
    Popescu V; Arion C; Dragomir D; Bleahu D; Popescu D; Hurduc V; Tiţeica M; Mateescu D; Ilinca D
    Rev Pediatr Obstet Ginecol Pediatr; 1989; 38(2):161-72. PubMed ID: 2511614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families.
    Kristjansdottir H; Saevarsdottir S; Gröndal G; Alarcón-Riquelme ME; Erlendsson K; Valdimarsson H; Steinsson K
    Arthritis Rheum; 2008 Dec; 58(12):3865-72. PubMed ID: 19035512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways.
    Ceribelli A; Andreoli L; Cavazzana I; Franceschini F; Radice A; Rimoldi L; Sinico RA; Carlsson M; Wieslander J; Tincani A
    Ann N Y Acad Sci; 2009 Sep; 1173():427-34. PubMed ID: 19758182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus.
    Jesus AA; Silva CA; Carneiro-Sampaio M; Sheinberg M; Mangueira CL; Marie SK; Liphaus BL
    Ann N Y Acad Sci; 2009 Sep; 1173():235-8. PubMed ID: 19758156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune response to proteins of proliferating cell nuclear antigen multiprotein complexes in patients with connective tissue diseases.
    Kaneda K; Takasaki Y; Takeuchi K; Yamada H; Nawata M; Matsushita M; Matsudaira R; Ikeda K; Yamanaka K; Hashimoto H
    J Rheumatol; 2004 Nov; 31(11):2142-50. PubMed ID: 15517625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies against C1q in systemic lupus erythematosus.
    Siegert CE; Breedveld FC; Daha MR
    Behring Inst Mitt; 1993 Dec; (93):279-86. PubMed ID: 8172577
    [No Abstract]   [Full Text] [Related]  

  • 18. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement and its breakdown products in SLE.
    Sturfelt G; Truedsson L
    Rheumatology (Oxford); 2005 Oct; 44(10):1227-32. PubMed ID: 15972354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis.
    Flierman R; Daha MR
    Mol Immunol; 2007 Jan; 44(1-3):133-8. PubMed ID: 16870257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.